Competitive Numerical Analysis for Stochastic Hiv/Aids Epidemic Model in a Two-Sex Population
| dc.contributor.author | Rafiq, Muhammad | |
| dc.contributor.author | Baleanu, Dumitru | |
| dc.contributor.author | Shoaib Arif, Muhammad | |
| dc.contributor.author | Naveed, Muhammad | |
| dc.contributor.author | Ashraf, Kaleem | |
| dc.contributor.author | Raza, Ali | |
| dc.date.accessioned | 2020-05-18T22:58:47Z | |
| dc.date.accessioned | 2025-09-18T12:08:23Z | |
| dc.date.available | 2020-05-18T22:58:47Z | |
| dc.date.available | 2025-09-18T12:08:23Z | |
| dc.date.issued | 2019 | |
| dc.description | Naveed, Muhamamd/0000-0002-4333-8226; Arif, Muhammad Shoaib/0000-0002-6009-5609; Rafiq, Muhammad/0000-0002-2165-3479; Raza, Ali/0000-0002-6443-9966 | en_US |
| dc.description.abstract | This study is an attempt to explain a reliable numerical analysis of a stochastic HIV/AIDS model in a two-sex population considering counselling and antiretroviral therapy (ART). The authors are comparing the solutions of the stochastic and deterministic HIV/AIDS epidemic model. Here, an endeavour has been made to explain the stochastic HIV/AIDS epidemic model is comparatively more pragmatic in contrast with the deterministic HIV/AIDS epidemic model. The effect of threshold number H* holds on the stochastic HIV/AIDS epidemic model. If H* < 1 then condition helps us to control disease in a two-sex human population while H* > 1 explains the persistence of disease in the two-sex human population. Lamentably, numerical methods such as Euler-Maruyama, stochastic Euler, and stochastic Runge-Kutta do not work for large time step sizes. The recommended structure preserving framework of the stochastic non-standard finite difference (SNSFD) scheme conserve all vital characteristics such as positivity, boundedness, and dynamical consistency defined by Mickens. The effectiveness of counselling and ART may control HIV/AIDS in a two-sex population. | en_US |
| dc.identifier.citation | Raza, A...et al. (2019). "Competitive Numerical Analysis for Stochastic Hıv/Aıds Epidemic Model in A Two-Sex Population",Iet Systems Biology, Vol. 13, No. 6, pp. 305-315. | en_US |
| dc.identifier.doi | 10.1049/iet-syb.2019.0051 | |
| dc.identifier.issn | 1751-8849 | |
| dc.identifier.issn | 1751-8857 | |
| dc.identifier.scopus | 2-s2.0-85075743196 | |
| dc.identifier.uri | https://doi.org/10.1049/iet-syb.2019.0051 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12416/11119 | |
| dc.language.iso | en | en_US |
| dc.publisher | inst Engineering Technology-iet | en_US |
| dc.relation.ispartof | IET Systems Biology | |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Diseases | en_US |
| dc.subject | Stochastic Processes | en_US |
| dc.subject | Epidemics | en_US |
| dc.subject | Patient Treatment | en_US |
| dc.subject | Finite Difference Methods | en_US |
| dc.subject | Two-Sex Human Population | en_US |
| dc.subject | Antiretroviral Therapy | en_US |
| dc.subject | Competitive Numerical Analysis | en_US |
| dc.subject | Stochastic Hiv-Aids Epidemic Model | en_US |
| dc.subject | Structure Preserving Framework | en_US |
| dc.subject | Stochastic Nonstandard Finite Difference Scheme | en_US |
| dc.subject | Snsfd Scheme | en_US |
| dc.subject | Deterministic Hiv-Aids Epidemic Model | en_US |
| dc.title | Competitive Numerical Analysis for Stochastic Hiv/Aids Epidemic Model in a Two-Sex Population | en_US |
| dc.title | Competitive Numerical Analysis for Stochastic Hıv/Aıds Epidemic Model in A Two-Sex Population | tr_TR |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Naveed, Muhamamd/0000-0002-4333-8226 | |
| gdc.author.id | Arif, Muhammad Shoaib/0000-0002-6009-5609 | |
| gdc.author.id | Rafiq, Muhammad/0000-0002-2165-3479 | |
| gdc.author.id | Raza, Ali/0000-0002-6443-9966 | |
| gdc.author.scopusid | 56072492500 | |
| gdc.author.scopusid | 55960372700 | |
| gdc.author.scopusid | 7005872966 | |
| gdc.author.scopusid | 57224647378 | |
| gdc.author.scopusid | 58953995300 | |
| gdc.author.scopusid | 57212019837 | |
| gdc.author.wosid | Raza, Ali/Abe-1951-2021 | |
| gdc.author.wosid | Arif, Muhammad Shoaib/Abc-4011-2020 | |
| gdc.author.wosid | Baleanu, Dumitru/B-9936-2012 | |
| gdc.author.wosid | Rafiq, Muhammad/Gnw-5095-2022 | |
| gdc.author.wosid | Naveed, Muhamamd/E-4965-2013 | |
| gdc.author.yokid | 56389 | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C4 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | Çankaya University | en_US |
| gdc.description.departmenttemp | [Raza, Ali; Shoaib Arif, Muhammad; Naveed, Muhammad] Air Univ, Dept Math, Stochast Anal & Optimizat Res Grp, PAF Complex E-9, Islamabad, Pakistan; [Rafiq, Muhammad] Univ Cent Punjab, Fac Engn, Lahore, Pakistan; [Baleanu, Dumitru] Cankaya Univ, Dept Math, TR-06530 Ankara, Turkey; [Baleanu, Dumitru] Inst Space Sci, Magurele, Romania; [Ashraf, Kaleem] Univ Management & Technol, Dept Math, Lahore, Pakistan | en_US |
| gdc.description.endpage | 315 | en_US |
| gdc.description.issue | 6 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q4 | |
| gdc.description.startpage | 305 | en_US |
| gdc.description.volume | 13 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q3 | |
| gdc.identifier.openalex | W2964451631 | |
| gdc.identifier.pmid | 31778127 | |
| gdc.identifier.wos | WOS:000499465900004 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 15.0 | |
| gdc.oaire.influence | 3.7623917E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | Male | |
| gdc.oaire.keywords | Acquired Immunodeficiency Syndrome | |
| gdc.oaire.keywords | Stochastic Processes | |
| gdc.oaire.keywords | Models, Statistical | |
| gdc.oaire.keywords | Anti-HIV Agents | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Female | |
| gdc.oaire.keywords | Sex Distribution | |
| gdc.oaire.popularity | 1.610301E-8 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0103 physical sciences | |
| gdc.oaire.sciencefields | 0101 mathematics | |
| gdc.oaire.sciencefields | 01 natural sciences | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 3.5139 | |
| gdc.openalex.normalizedpercentile | 0.92 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 24 | |
| gdc.plumx.crossrefcites | 24 | |
| gdc.plumx.mendeley | 22 | |
| gdc.plumx.pubmedcites | 4 | |
| gdc.plumx.scopuscites | 27 | |
| gdc.publishedmonth | 12 | |
| gdc.scopus.citedcount | 27 | |
| gdc.virtual.author | Baleanu, Dumitru | |
| gdc.wos.citedcount | 28 | |
| relation.isAuthorOfPublication | f4fffe56-21da-4879-94f9-c55e12e4ff62 | |
| relation.isAuthorOfPublication.latestForDiscovery | f4fffe56-21da-4879-94f9-c55e12e4ff62 | |
| relation.isOrgUnitOfPublication | 26a93bcf-09b3-4631-937a-fe838199f6a5 | |
| relation.isOrgUnitOfPublication | 28fb8edb-0579-4584-a2d4-f5064116924a | |
| relation.isOrgUnitOfPublication | 0b9123e4-4136-493b-9ffd-be856af2cdb1 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 26a93bcf-09b3-4631-937a-fe838199f6a5 |
